Biomet hires Morgan Stanley to help explore strategic alternatives

By Lisa Kerner

Erie, Pa., April 6 - Biomet, Inc. said that Morgan Stanley & Co. Inc. is assisting the company in exploring strategic alternatives focused on enhancing shareholder value.

No decisions have been made, there is no assurance that exploration will result in any specific action and Biomet does not expect to disclose developments related to alternatives unless required.

"We believe that this review is a prudent exercise and is consistent with management's commitment to our shareholders and team members," interim president and chief executive officer Daniel P. Hann said in a news release.

Biomet, located in Warsaw, Ind., and its subsidiaries design, manufacture and market products used primarily by musculoskeletal medical specialists in both surgical and non-surgical therapy.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.